CD4 and breast carcinoma: Silei Sui et al. constructed an immune cell infiltration-based immune score model based on resting CD4+ T cells, regulatory T cells, gamma-delta T cells, activated NK cells, monocytes, and M0 macrophages to predict the prognosis of breast cancer patients and the effect of chemotherapy (Sui et al., 2020).